Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Current assets
Cash and equivalents	$ 2,858	$ 2,801
Accounts and other current receivables, net	1,646	1,691
Inventories	1,480	1,430
Prepaid expenses and other	603	602
Current assets held for disposition	46	50
Total current assets	6,633	6,574
Property, plant and equipment, net	4,274	4,289
Other assets
Goodwill	2,633	2,595
Other intangible assets, net	1,091	1,111
Other	1,028	977
Total other assets	4,752	4,683
Total assets	15,659	15,546
Current liabilities
Current maturities of long-term debt and lease obligations	3	3
Accounts payable and accrued liabilities	2,330	2,612
Current income taxes payable	102	126
Current liabilities held for disposition	3	3
Total current liabilities	2,438	2,744
Long-term debt and lease obligations	2,784	2,779
Other long-term liabilities	1,762	1,743
Equity
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2017 and 2016	683	683
Common stock in treasury, at cost, 140,783,486 shares in 2017 and 143,890,064 shares in 2016	(7,810)	(7,995)
Additional contributed capital	5,908	5,958
Retained earnings	14,323	14,200
Accumulated other comprehensive (loss) income	(4,418)	(4,556)
Total Baxter shareholders’ equity	8,686	8,290
Noncontrolling interests	(11)	(10)
Total equity	8,675	8,280
Total liabilities and equity	$ 15,659	$ 15,546